This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true regarding the clinical course of chronic lymphocytic leukemia? a. ... (Read 74 times)

cool

  • Hero Member
  • *****
  • Posts: 570
Which of the following is true regarding the clinical course of chronic lymphocytic leukemia?
 
  a. Aggressive disorder that presents with severe bleeding and anemia
  b. Benign disorder that rarely requires treatment
  c. Mild symptoms but usually fatal within 6 months
  d. Incurable but with a median survival of approximately 10 years

Question 2

What is the preferred specimen to evaluate cellular morphology in the lymphoproliferative disorders?
 
  a. Peripheral blood
  b. Bone marrow
  c. Node frozen sections
  d. Touch imprints of nodes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

polinasid

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: D
Chronic lymphocytic leukemia is regarded as an indolent lymphoproliferative disorder. It is currently incurable, and the median survival is up to 10 years.

Answer to Question 2

ANS: D
Touch imprints can be prepared and fixed in formalin or alcohol solution or air-dried for Wright-Giemsa staining to assess cell morphology.





 

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library